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Abstract: Introduction: We aimed to compare the effect of nettle extract and pumpkin seed on Prostate Specific Anti-
gen (PSA) and international prostate symptoms score (IPSS) in patients taking alfa-blocker for benign prostatic
hyperplasia (BPH). Materials and Methods: For this purpose, 90 outpatients were studied in three groups, in-
cluding men over 40 years of age with benign prostatic enlargement. The first group (Urtidin) contained con-
sumers of nettle extract from Barijessence Company called Urtidin tablets with tamsulosin; the second group
took tablets containing pumpkin seed extract called Prosta Barij and tamsulosin; the third group (Control) re-
ceived only tamsulosin for three months. Patients were not randomly assigned to the groups. PSA, IPSS, and re-
lated factors were evaluated and analyzed using SPSS software. Results: 89 patients completed the study (30/89
in Urtidin group with a mean age of 62.4±7.39 years, 29/89 in Prosta Barij group with a mean age of 65.9±7.32
years, and 30/89 in the control group with a mean age of 64.7±8.64 years). The results showed that nettle and
pumpkin seed extracts affect PSA in patients taking tamsulosin for BPH. Also, after the intervention, IPSS had
a significant decrease compared with baseline in both drug treatment groups. There was no significant differ-
ence in these three types of treatment. Conclusion: It seems that the desired herbal products did not have a
synergistic effect with alpha blockers in the control and treatment of BPH but they can affect the serum PSA
level.
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1. Introduction
Benign prostatic hyperplasia (BPH) is a common complaint
and the fourth most common diagnosis in men over 50 years
of age (1). Conventional treatment for benign prostatic hy-
perplasia includes drug therapy with alpha-adrenergic block-
ers or 5 alpha reductase inhibitors such as finasteride and
combination drug therapy, or prostate surgery (2). Prostate
surgery is known as the standard treatment for BPH. How-
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ever, this method has long-term complications including ret-
rograde ejaculation, bladder neck stenosis, and impotence
(3).
On the other hand, the use of drug therapy for BPH re-
duces its side effects (4). Medications commonly pre-
scribed for urinary tract problems include; α1-blockers, and
5α-reductase inhibitors, Phyto-pharmaceuticals. Some α1-
blockers may be associated with orthostatic hypotension,
and 5α-reductase inhibitors may cause sexual dysfunction
(4). Considering the side effects of chemical drugs, many re-
searchers have focused on the use of medicinal plants. Nettle
plant with the scientific name of Urtica dioica is a perennial
herbaceous plant with a height of about one meter and has
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trichomes capable of biting (5, 6). Urtica dioica is a genus of
Urtica and the reason for its name is that it grows on the sur-
face of the stem and leaves of the plant. This plant has two
bases. Non-female flowers are placed on both bases of the
plant at the same time. The parts of the plant used are fresh
leaves, roots, and seeds (7,8).
Research has shown that nettle can improve symptoms of
BPH and inhibit the conversion of testosterone to dihy-
drotestosterone by the enzyme 5-alpha reductase (9-11).
This plant can also bind directly to sex hormone-binding
globulin (SHBG) and prevent hormones from binding to pro-
tein (12). Other studies have shown that nettle can prevent
the protein complex from binding to hormones and finally
to receptors in prostate cells or reduce estrogen production
by inhibiting the enzyme required for this function (7, 10).
Pumpkin is an herbal medicine that has been used around
the world for centuries and its therapeutic effect has been
recommended in many reference books and manuscripts.
The genus Cucurbita includes very wide species in Europe,
Asia, and America. Cucurbita pepo in the form of soft
ethanolic extract of pumpkin seeds has been used mainly as
a treatment for various problems related to enlarged prostate
gland or overactive bladder during the last thirty years in Eu-
ropean societies (13, 14). The active ingredients in pump-
kin seeds include sterols δ7, δ5 and δ8. Sterols δ7 are pre-
dominant in this plant and are considered as key active com-
pounds in pumpkin seeds in the treatment of benign pro-
static hyperplasia. Very small amounts of sterols δ5 and δ8
are also present in pumpkin seeds (13, 15). Large amounts of
unsaturated carotenoids and fatty acids and fat-soluble vita-
mins such as vitamin E are involved in the function of these
sterols (15).
Previous experimental studies confirm support for the role
of pumpkin seeds in the treatment of BPH (16-18). Pumpkin
extract inhibits the enzyme 5-alpha reductase and prevents
the conversion of testosterone to dihydrotestosterone (19).
Moreover, many of its vitamins and minerals, including vi-
tamin E, vitamin B6, and zinc, have anti-cancer activity and
act as antioxidants (20).
With respect to the long-term complications of prostate
surgery and the mentioned benefits of herbal plants, herbal
treatment of this disease is of interest, so we aimed to com-
pare the effect of nettle extract and pumpkin seed on PSA and
IPSS in patients who consume tamsulosin for BPH.
2. Materials and Methods
2.1. Materials
Tamsulosin
Tamsulosin for patients with BPH usually starts with 0.4 mg
once daily. It is better to be used half an hour before bed-
time. If a person does not receive a proper response after two
to four weeks, the dose may be increased to 0.8 mg once daily.
If tamsulosin slow-release capsules are prescribed, the maxi-
mum dose is 0.4 mg once daily (21). In this trial we prescribed
tamsover 0.4 (Actoverco Pharmaceuticals Company, Iran) ev-
ery night at bedtime.
Urtidin Barij (Barijessence Company, Iran) Coated Tablets
This pill has nettle root extract and is used to relieve urination
problems (such as frequent urination, dribbling and delayed
urination) as well as improves overactive bladder (22). In this
trial we prescribed this drug twice daily.
Prosta Barij (Barijessence Company, Iran) soft capsule
Prosta Barij soft capsule contains pumpkin seed oil with the
scientific name of Cucurbita pepo and vitamin E, which is
prescribed for prevention and elimination of urinary prob-
lems and it may prevent hair loss (23). In this trial we pre-
scribed this drug once daily.
3. Methods
In this study, 90 outpatients in the clinic of Shohada-Tajrish
Hospital in Tehran, Iran affiliated to the urology department
were examined in three groups, including men over 40 years
with benign prostatic enlargement:
1- The first group (Urtidin) contains consumers of nettle
extract from Barijessence Company called Urtidin tablets
with tamsulosin; 2- The second group (Prosta Barij) contains
pumpkin seed extract called Prosta Barij and tamsulosin;
3- The third group (Control) received only tamsulosin for
three months.
The study was conducted in accordance with the principles
of the Declaration of Helsinki (1996) and Good Clinical Prac-
tice standards. The study protocol, informed-consent form,
and the other study-related documents were reviewed and
approved by the Human Research Ethics Committee of Is-
lamic Azad University of Medical Sciences, School of Phar-
macy) (IR.IAU.PS.REC.1398.283). All patients were able to
read, and voluntarily signed the informed consent, which
was in the patients’ language.
Patients more than 40 years old with symptomatic BPH were
included. Those with urinary system infection, urolithiasis,
urinary retention, urinary incontinence, urethral stricture,
urinary system malignancies, physical and mental disabil-
ities, participation in another research, hernia, hematuria,
prostate cancer and neurogenic bladder were excluded. One
patient was lost to follow-up. Finally, 89 patients completed
the study, 30 patients in the Uritidin group, 29 in the Prosta
Barij group, and 30 patients in the control group. Interna-
tional Prostate Symptom Score (IPSS) and total Prostate Spe-
cific Antigen (PSA) were primary outcomes and Free PSA and
serum creatinine level were secondary outcomes.
PSA: PSA is a type of protein made by normal cells as well
as malignant prostate glands. The PSA test is used to check
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the amount of PSA in the blood, which is done by analyzing a
blood sample in a laboratory.
International Prostate Symptom Score (IPSS) question-
naire: The IPSS questionnaire is an 8-item questionnaire,
which consists of seven questions about symptoms and one
question about quality of life. The IPSS score was standard-
ized into three categories: mild, moderate and severe. Limi-
tations of this questionnaire include lack of assessment of in-
continence, post-urinary symptoms, and discomfort caused
by each of the individual symptoms. A score of 0 to 7 is
classified as mildly symptomatic, 8-19 as moderately symp-
tomatic, and 20-35 as severely symptomatic. The mentioned
parameters were measured in each group and the results
were compared before and after taking the supplements.
Since we did not find a similar study comparing the three
groups, 30 participants were allocated to each group without
using a sample size formula.
3.1. Analysis of statistical data
Statistical analysis in this study was performed in two parts.
In the first part, a frequency table was used to report the de-
scriptive statistics of the participants. For qualitative vari-
ables, frequency and percentage indices and for quantitative
variables, mean and standard deviation were reported.
Because of normal data distribution in the study groups,
parametric tests can be used to analyze the data and test the
hypotheses. Paired sample t test was used to determine the
significant difference before and after the intervention. One-
Way ANOVA along with Tukey Post Hoc tests were used to de-
termine the significant differences between Urtidin, Prosta
Barij and control groups. Finally, Fisher’s exact and Chi-
square tests were used to determine the relationship between
multivariate qualitative variables. The significance level of
statistical tests is considered to be 0.05. Statistical analysis
was performed using the SPSS (Statistical Package for Social
Science, Chicago, Illinois) version 24.0.
4. Results
4.1. Descriptive statistics
30 patients were in the Urtidin intervention group, 29 pa-
tients were in the Prosta Barij intervention group and 30 pa-
tients were in the control group. The mean±SD ages of the
participants in the Urtidin, Prosta Barij, and control groups
were 62.40±7.39, 65.90± 7.32, and 64.07± 8.64 years, respec-
tively (table 1).
The highest history of urinary tract infection was related to
10.3% of participants in the Prosta Barij group and the high-
est history of hypertension, diabetes and allergies were re-
lated to 36.7%, 16.7% and 13.3% of the participants in an Ur-
tidin group.
4.2. Inferential analysis of data
Due to the normality of the data distribution, which was
examined by Kolmogorov-Smirnov (KS) test, Paired sample
t test and one-way ANOVA was used in conjunction with
Tukey’s post hoc tests. Fisher’s exact test and Pearson’s Chi-
square were also used to determine the relationship between
multivariate qualitative variables.
4.3. Investigation of the effect of nettle extract
and pumpkin seeds on Lab Data
In this section, tota, free PSA, and creatinine (Cr) were evalu-
ated separately.
Evaluation of total PSA in three groups
ANOVA was used to evaluate the total PSA index in the three
groups and the difference before and after the intervention
was analyzed.
The results of total PSA showed that there was no signifi-
cant difference between the three groups before and after
the intervention (P>0.05). There was a significant difference
between the two intervention groups from before to three
months after the intervention (P<0.05). In other words, in the
intervention Urtidin and Prosta Barij groups, the value of this
index decreased significantly three months after the inter-
vention, but in the control group, this index did not change
although the. decrease in herbal medicine groups was not
clinically significant.
Evaluation of free PSA in three groups
Analysis of variance was used to evaluate the free PSA in
three groups and the difference before and after the inter-
vention was analyzed. The results of free PSA showed that
there was no significant difference between the three groups
before the intervention (P>0.05) but after the intervention
there was a significant difference between the three groups
(P<0.05). Post hoc test showed that the Urtidin group had a
higher and significant mean than the control group. But the
Prostat Barij group and the control group as well as the two
intervention groups did not differ significantly. There was no
significant difference between the amount of free PSA before
and after 3 months of intervention in any of the three groups
(P>0.05).
Evaluation of Creatinine (Cr) in three groups
Table 4 shows the serum Cr levels. As shown, there was no
significant difference between the three groups before and
after the intervention (P>0.05). There is no significant dif-
ference between the serum levels of Cr in each group before
and after the intervention (P>0.05).
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4.4. Evaluation of the effect of nettle extract
and pumpkin seed on the international prostate
symptom score (IPSS)
The results of IPSS score in each of these three categories
were evaluated (Table 5). 96.6% of all participants in this
study had a moderate score (scores 8 to 19) before the inter-
vention. The results of 3 months after the intervention also
show that all participants reported a mild IPSS index (scores
0 to 7).
Then, to evaluate the IPSS index in three groups, ANOVA was
used and the difference before and after the intervention was
analyzed. The results showed that there was no significant
difference between the three groups before and after the in-
tervention (P>0.05). Post hoc test showed that the Prosta
Barij group had a higher and more decreased mean than the
control group but the difference was not significant. In the
control group as well as two intervention groups a signifi-
cant decrease in IPSS was demonstrated after three months
(P<0.05).
5. Discussion and conclusion
In vitro, plant extracts can have anti-inflammatory, anti-
androgenic and oestrogenic effects; decrease sexual hor-
mone binding globulin; inhibit growth factor-stimulated
proliferation of prostatic cells, α-adrenoceptors, 5 α-
reductase, muscarinic cholinoceptors; and neutralize free
radicals (24-26).
The in vivo effects of these compounds are uncertain, and
the precise mechanisms of plant extracts remain unclear. Ac-
cording to the latest European association of urology (EAU)
guideline, herbal drug “hexane extracted Serenoa repens
(HESr)” improves Qmax and results in fewer voids/night
compared to placebo. Some other available EU herbal
medicinal products such as saw palmetto, pumpkin seed,
and Urtica were listed in this guideline(27).
In the present study, the effect of nettle extract and pumpkin
seed on PSA and IPSS levels of patients taking tamsulosin
with benign hyperplasia was discussed in three groups. The
overall results of testing the hypotheses of this study indicate
that nettle and pumpkin seed extracts affect the PSA of
patients taking tamsulosin with BPH. In other words, in the
intervention groups of Urtidin and Prosta Barij, the value
of total PSA decreased significantly three months after the
intervention, but in the control group, this index did not
change significantly. There was no significant difference
before and after three months of intervention in the amount
of free PSA in the three groups. Also, three months after
the intervention, Cr had a significant decrease compared
to before the intervention. But there were no significant
changes in the control group. The results of this hypothesis
are consistent with the results of other studies (11, 16, 20,
28-35).
Also, after the intervention, IPSS significantly decreased
compared to before the intervention in both treatment
groups as well as the control group. But when the three
groups were compared, no significant change was reported.
The results of this hypothesis are not consistent with the
results of several other studies (4, 16, 30, 35, 36).
Consistent with our results AUA guideline 2010 also did
not recommended use of saw palmetto and Urtica dioica
extracts in the management of patients with BPH because
of controversial results (37), while encouraging results have
been published for the hexane extract of Serenoa repens and
for the combination of Serenoa repens (Saw Palmetto Berry)
with lycopene and selenium.
According to the above, we cannot conclude that the desired
herbal products have a synergistic effect with alpha blockers
in the treatment of BPH. Therefore, we need clinical trials
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Table 1: Summary of the participants’ information and history of underlying diseases
Urtidin (n=30) Prosta Barij (n=29) Control (n=30)
Number Percent Number Percent Number Percent
History of urinary No 30 100 26 89.7 30 100
tract infection Yes 0 0 3 10.3 0 0
History of No 19 63.3 23 79.3 23 76.7
hypertension Yes 11 36.7 6 20.7 7 23.3
History of No 25 83.3 25 86.2 30 100
diabetes mellitus Yes 5 16.7 4 13.8 0 0
History of No 26 86.7 29 100 29 96.7
allergies Yes 4 13.3 0 0 1 3.3







Age 62.4 7.39 65.90 7.32 64.07 8.64
Table 2: Summary of Total PSA statistical analysis in the treatment groups (before and after the intervention)
PSA Total Urtidin (n=30) Prosta Barij (n=29) Control (n=30) P-value*
Mean SD Mean SD Mean SD
Before 1.44 1.68 1.47 0.92 0.85 0.27 =0.068 P
PSA total 3 months later 1.35 1.51 1.38 0.85 0.87 0.33 =0.109 P
The amount of difference 0.098 decrease 0.095 decrease 0.25 increase
P-value** P=0.005 P=0.002 P=0.224
* One-Way ANOVA / ** Paired Sample T Test
Table 3: Summary of free PSA statistical analysis in the treatment groups (before and after the intervention).
PSA Free Urtidin (n=30) Prosta Barij (n=29) Control (n=30) P-value*
Mean SD Mean SD Mean SD
Before 0.38 0.42 0.31 0.20 0.24 0.12 P=0.136
PSA total 3 months later 0.46 0.45 0.30 0.20 0.23 0.16 P=0.015
The amount of difference 0.078 increase 0.013 decrease 0.002 increase
P-value** P=0.166 P=0.202 P=0.907
* One-Way ANOVA / ** Paired Sample T-Test
Table 4: Summary of statistical analysis of Cr in the treatment groups (before and after the intervention)
Cr Urtidin (n=30) Prosta Barij (n=29) Control (n=30) P-value*
Mean SD Mean SD Mean SD
Before 1.19 0.20 1.00 0.10 1.04 0.09 P>0.05
Cr 3 months later 1.14 0.18 0.96 0.11 1.017 0.134 P>0.05
The amount of difference 0.05 decrease 0.043 decrease 0.027 decrease
P-value** P>0.05 P>0.05 P>0.05
* One-Way ANOVA / ** Paired Sample T-Test
Table 5: Summary of statistical analysis of IPSS in the treatment groups (before and after the intervention)
Urtidin (n=30) Prosta Barij (n=29) Control (n=30) P-value*
Mean SD Mean SD Mean SD
Before 13.40 1.45 14.14 3.03 12.83 1.72 P=0.084
IPSS 3 months later 6.04 1.11 5.97 1.12 5.33 1.91 P=0.096
The amount of difference 7.36 decrease 8.17 decrease 7.50 decrease
P-value** P=0.001 P=0.001 P=0.001
* One-Way ANOVA / ** Paired Sample T-Test
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